BPH Treatment Da Nang: Medical & Minimally Invasive Care – Dr. Dat

Author & Medical Reviewer: Dr. Dang Phuoc Dat (Bs CKI Đặng Phước Đạt) – Specialist Level I in Urology, Andrology & Reconstructive Surgery | Updated: October 22, 2026

Benign Prostatic Hyperplasia (BPH) is a universal part of male aging, affecting over 50% of men by age 60 and 80% by age 80. Effective BPH treatment Da Nang is not about waiting until acute urinary retention forces emergency surgery—it is about early, individualized medical management that restores uninterrupted night sleep, preserves sexual function, and safeguards the bladder and kidneys.

Quick Clinical Summary: Quick Clinical Summary: Following European Association of Urology (EAU) guidelines, BPH treatment is stratified by IPSS symptom score, prostate volume, and Post-Void Residual (PVR): (1) Watchful Waiting & Lifestyle Modification for mild LUTS (IPSS ≤ 7); (2) Targeted Pharmacotherapy combining Alpha-1 blockers (rapid urethral relaxation), 5-ARIs (long-term gland shrinkage for prostates > 40 mL), Beta-3 agonists (for nocturia/urgency), or daily Tadalafil 5 mg; and (3) Minimally Invasive Surgery (Rezum, Bipolar TURP, HoLEP) when medications fail.

1. Voiding vs. Storage Symptoms: Why Customizing Your BPH Medication Matters

During consultation at Family Hospital Da Nang, Dr. Dang Phuoc Dat separates male Lower Urinary Tract Symptoms (LUTS) into two physiological categories that require different pharmacological targets:

• Voiding (Obstructive) Symptoms: Hesitancy, straining to start the stream, weak or intermittent flow, and incomplete emptying—caused directly by static and dynamic prostatic compression of the urethra.
• Storage (Irritative) Symptoms: Nocturia (waking ≥ 2 times/night to void), daytime frequency, and sudden urgency—caused by secondary overactivity of the bladder’s detrusor muscle working against chronic outlet resistance.

EAU Evidence-Based Pharmacological Classes for BPH Treatment

Medication Class	Representative Agents	Primary Mechanism of Action	Clinical Pearls & Precautions
Selective Alpha-1 Blockers	Alfuzosin 10 mg, Tamsulosin 0.4 mg, Silodosin	Relaxes smooth muscle in the prostate stroma and bladder neck, improving flow within 3 – 5 days	Take after dinner; inform your ophthalmologist prior to cataract surgery (IFIS); Silodosin/Tamsulosin may cause dry ejaculation
5-Alpha Reductase Inhibitors (5-ARIs)	Dutasteride 0.5 mg, Finasteride 5 mg	Blocks conversion of Testosterone to DHT inside the prostate, shrinking gland volume by 20% – 25% and halving retention risk	Indicated when prostate > 40 mL; reduces serum PSA by ~50% after 6 months (multiply PSA by 2 for cancer screening)
Antimuscarinics / Beta-3 Agonists	Solifenacin, Mirabegron	Calms involuntary detrusor contractions to reduce nocturia and sudden urinary urgency	Contraindicated as monotherapy if Post-Void Residual (PVR) exceeds 150 mL
Daily PDE5 Inhibitor	Tadalafil 5 mg once daily	Relaxes lower urinary tract smooth muscle while simultaneously restoring erectile function	Ideal single-pill choice for men with coexisting BPH and Erectile Dysfunction

EAU Evidence-Based Pharmacological Classes for BPH Treatment

INTERNATIONAL CLINICAL CARE PATHWAY: BPH TREATMENT DA NANG
1. PRECISION DIAGNOSTICS	2. PERSONALIZED THERAPY	3. RECOVERY & AFTERCARE
• 1-on-1 Specialist Evaluation • High-Resolution CT / Doppler Imaging • EAU / AUA Clinical Stratification Focus: Benign Prostatic Hyperplasia (BPH) & Male LUTS	• Minimally Invasive Priority • Organ & Neurovascular Preservation • Strict Sterile Hospital OR Standards Modality: Voiding (Obstructive) vs. Storage (Irritative) Symptoms	• Rapid Return to Travel & Work • Direct International Insurance Billing • Long-Term Recurrence Prevention Key Entity: Alpha-1 Adrenergic Blockers (Alfuzosin, Tamsulosin, Silodosin)
Dr. Dang Phuoc Dat • Da Nang Urology – Andrology – Aesthetic Center (162 Te Hanh, Hoa Xuan, Da Nang) • Zalo/Phone/WhatsApp: 07777 43 777

2. When to Transition from Oral Pills to Minimally Invasive Procedures

Dr. Dang Phuoc Dat monitors medical BPH patients every 6 months with uroflowmetry and PVR ultrasound, recommending procedural intervention when:

1. Ejaculation-Sparing Minimally Invasive Therapy (e.g., Rezum Water Vapor Therapy / TUIP): Ideal for men with moderate prostates (30–80 mL) who wish to discontinue lifelong medications while preserving antegrade ejaculation.
2. Bipolar TURP or Holmium Laser Enucleation (HoLEP): Indicated when symptom progression persists despite combination therapy, PVR rises > 100–150 mL, or complications (acute retention, bladder stones, recurrent UTIs, renal back-pressure) develop.

3. Five Evening Habits That Reduce Nocturia by Up to 50%

Alongside prescribed therapy, behavioral fluid management significantly reduces nighttime awakenings:

• Restrict Fluid & Soup Intake After 7:00 PM (while maintaining 1.5–2.0 liters of hydration during morning and afternoon hours).
• Eliminate Evening Alcohol and Caffeine: Alcohol suppresses antidiuretic hormone (ADH) and impairs detrusor contractility, while caffeine directly irritates bladder neck receptors.
• Practice ‘Double Voiding’ Before Bedtime: Void normally, wait 1–2 minutes, and relax to void a second time so the bladder starts the night completely empty.

Clinical Red Flags: When to Seek Immediate Urological Care

URGENT MEDICAL RED FLAGS:

• Cold & Allergy Medication Warning: Men with BPH must avoid over-the-counter decongestants containing Pseudoephedrine or Phenylephrine, as well as first-generation antihistamines (Chlorpheniramine/Diphenhydramine). These agents strongly contract alpha-receptors at the bladder neck and impair detrusor contraction, frequently triggering acute urinary retention overnight.

Clinical Perspective from Da Nang: Clinical Perspective from Da Nang: Many men waking 4–5 times a night blame their prostate exclusively. When Dr. Dang Phuoc Dat evaluates a 3-Day Frequency-Volume Bladder Diary, over 60% of these patients actually have Nocturnal Polyuria—where >33% of their 24-hour urine volume is produced at night due to peripheral leg edema mobilization, mild heart failure, or obstructive sleep apnea. Treating the prostate without addressing nocturnal polyuria will not cure nighttime waking.

Frequently Asked Questions (International Patient Guide)

Question 1: Do I have to take BPH medications for the rest of my life?

For 5-ARIs (such as Dutasteride) that shrink a large gland, continuous therapy is needed to maintain volume reduction. For men with mild-to-moderate symptoms on an Alpha-1 blocker alone who adopt strict evening fluid habits, a supervised trial of medication tapering (especially during warm summer months) can be evaluated.

Question 2: How often should a patient on BPH medication have a check-up in Da Nang?

After an initial 4-to-6-week review to confirm symptom relief and medication tolerance, stable BPH patients should undergo a check-up every 6 to 12 months for uroflowmetry, PVR ultrasound, and annual PSA screening.

Question 3: Should men with an enlarged prostate avoid sexual activity?

No. Regular, comfortable sexual activity and ejaculation actually promote prostatic fluid drainage and reduce pelvic venous congestion.